Related Experiment Video
Updated: Apr 4, 2026

11:08
Proofreading and DNA Repair Assay Using Single Nucleotide Extension and MALDI-TOF Mass Spectrometry Analysis
Published on: June 19, 2018
10.3K
Deficient mismatch repair: Read all about it (Review)
1Department of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, St. James University Hospital, Leeds, LS9 7TF, UK.
International Journal of Oncology
|August 29, 2015
Summary
Defects in DNA mismatch repair (MMR) proteins cause microsatellite instability (MSI), crucial for identifying Lynch syndrome. Current diagnostic tests for deficient MMR (dMMR) tumors have limitations, necessitating advanced screening technologies.
Area of Science:
- Oncology
- Genetics
- Cancer Diagnostics
Background:
- Microsatellite instability (MSI) arises from DNA mismatch repair (MMR) defects, present in up to 15% of sporadic colorectal cancers.
- Deficient MMR (dMMR) is linked to Lynch syndrome, an inherited cancer predisposition, affecting approximately 25% of dMMR colon cancers.
- Identifying Lynch syndrome is vital for patient and family screening and monitoring.
Purpose of the Study:
- To review the limitations of current diagnostic criteria for Lynch syndrome.
- To explain current and emerging screening technologies for dMMR tumors.
- To assess the prognostic and predictive value of dMMR in colorectal and extracolonic cancers.
Main Methods:
- Review of current literature on dMMR, MSI, and Lynch syndrome diagnostics.
- Discussion of immunohistochemistry, microsatellite testing, and next-generation sequencing.
- Assessment of dMMR status in colorectal, endometrial, ovarian, gastric, and melanoma cancers.
Main Results:
- Current diagnostic criteria for Lynch syndrome have limitations in sensitivity and specificity.
- Next-generation sequencing may offer improved accuracy over existing methods.
- dMMR status has established prognostic and predictive value in colorectal tumors, but less is known for extracolonic tumors.
Conclusions:
- There is a need for improved diagnostic methods and further research into dMMR in extracolonic cancers.
- Large-scale clinical trials are recommended to clarify the role of dMMR in Lynch syndrome-associated extracolonic tumors.
- Enhanced understanding of dMMR can improve patient management and screening strategies for hereditary cancer syndromes.

